Healthcare Sales & Marketing Network News: transmucosal

Searching News Database: transmucosal

HSMN NewsFeed - 8 Jun 2020
Neurelis Announces Rapid and Broad Payer Coverage of the Company's Flagship Product, VALTOCO(R) (Diazepam Nasal Spray)
Biopharmaceuticals Drug Delivery Reimbursement

HSMN NewsFeed - 4 Jun 2019
Braeburn Announces Publication of Phase 3 Study Results Showing Long-term Safety and Effectiveness of BRIXADI(TM) (buprenorphine) Extended-Release Injection for the Treatment of Opioid Use Disorder
Biopharmaceuticals

HSMN NewsFeed - 3 Dec 2018
Neurelis Announces Acquisition Of Aegis Therapeutics, A Leading Drug Delivery Technology Company
Biopharmaceuticals Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 23 Nov 2018
Indivior Announces Health Canada Approval of SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for Patients with Moderate to Severe Opioid Use Disorder
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 May 2018
Indivior Announces Regulatory Submission to Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 1 Mar 2018
SUBLOCADE(TM) (Buprenorphine Extended-Release) is Now Available as First and Only Monthly Injectable Buprenorphine in the U.S. to Treat Patients with Moderate to Severe Opioid Use Disorder
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 13 Jun 2017
Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE(R) in Canada for Opioid Drug Dependence
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 20 Sep 2016
Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 13 Aug 2015
BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS(R) (fentanyl buccal soluble film) CII
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 1 Apr 2015
Corium Announces Appointment of Eric H. Bjerkholt to Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 5 Sep 2013
ULURU Inc. Extends The International Altrazeal(R) License To Include Additional Territories
Devices Wound Care Licensing

HSMN NewsFeed - 26 Aug 2013
ULURU Inc. Announces A Publication In The International Wound Journal On A Clinical Study Using Altrazeal(R)
Devices Wound Care

HSMN NewsFeed - 28 May 2013
ULURU Inc. Announces Publication On Altrazeal(R) In The International Journal Of Molecular Sciences
Devices Wound Care

HSMN NewsFeed - 15 Oct 2012
BioDelivery Sciences Announces the Launch of BREAKYL (BEMA Fentanyl) in the E.U.
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 3 May 2012
ULURU Inc. Provides Update of Clinical Activities for Altrazeal
Devices Wound Care

HSMN NewsFeed - 23 Feb 2012
ULURU Inc. Announces Approval to Market Altrazeal(R) in Australia
Biopharmaceuticals Wound Care Regulatory

HSMN NewsFeed - 17 Jan 2012
ULURU Inc. Completes Altrazeal(R) License Agreement for Europe
Devices Wound Care Licensing

HSMN NewsFeed - 6 Jan 2012
Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 27 Oct 2011
ULURU Inc. Announces Additional Data Supporting Altrazeal(R) Use in Diabetic Foot Ulcers
Devices Wound Care

HSMN NewsFeed - 14 Jan 2011
Orexo and Invida Jointly Announce Agreement for Abstral(TM) in Asia Pacific
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 10 Jan 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Dec 2010
XIAFLEX(R) Effective in Nonsurgically Treating MP and PIP Joints with Dupuytren's Contractures in Second Pivotal Study
Biopharmaceuticals

HSMN NewsFeed - 7 Jun 2010
ULURU Inc. Announces Senior Management Change
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Apr 2010
Cephalon Completes Acquisition of Swiss Pharmaceutical Company Mepha
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Apr 2010
ULURU Inc. Announces the Appointment of Dr. Jeffrey A. Stone to the Board of Directors
Biopharmaceuticals Drug Delivery Wound Care Personnel

HSMN NewsFeed - 5 Apr 2010
Cephalon Completes Acquisition of Ception Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Mar 2010
Auxilium Announces Promotion of Benjamin Del Tito Jr., Ph.D. to Executive Vice President, Regulatory Affairs and Project Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Mar 2010
INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 8 Mar 2010
Auxilium Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2010
Transcept Pharmaceuticals Provides Update on Intermezzo(R) Regulatory Review
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Feb 2010
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Feb 2010
Cephalon, Inc. Announces Agreement to Acquire Mepha AG
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Jan 2010
Cephalon Announces Executive Leadership Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jan 2010
Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2010
Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2009
Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
Biopharmaceuticals Generics Litigation FDA

HSMN NewsFeed - 5 Nov 2009
Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Oct 2009
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Oct 2009
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Oct 2009
AcelRx Pharmaceuticals Hires Nigel Ray as Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Sep 2009
ULURU Inc. Presents Data on Negative Pressure Related to Altrazeal(TM) at the Diabetic Limb Salvage Conference in Washington, D.C.
Devices Wound Care

HSMN NewsFeed - 24 Sep 2009
Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Sep 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Votes Unanimously 12-0 to Recommend Approval of XIAFLEX(TM) for Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 16 Sep 2009
ULURU Inc. Presents Results of First Randomized Clinical Trial for Altrazeal(TM) at the Symposium on Advanced Wound Care (SAWC) Fall Meeting in Washington D.C.
Devices Wound Care

HSMN NewsFeed - 11 Sep 2009
Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain
Biopharmaceuticals

HSMN NewsFeed - 18 Aug 2009
Abbott Announces Partnership with Velcera to Bring New Pain Medication for Dogs to Market
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 31 Jul 2009
Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 31 Jul 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Confirms Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jun 2009
Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Jun 2009
U.S. Food and Drug Administration's Arthritis Advisory Committee Sets Tentative Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's Contracture
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Jun 2009
Cephalon Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder and Narcolepsy
Biopharmaceuticals

HSMN NewsFeed - 5 May 2009
ULURU Inc. Announces Altrazeal(TM) Clinical Experience Published in the International Wound Journal
Biopharmaceuticals Wound Care

HSMN NewsFeed - 28 Apr 2009
XIAFLEX(TM) for the Treatment of Dupuytren's Contracture Receives Priority Review From the U.S. Food and Drug Administration
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Apr 2009
ULURU Inc. Signs Offer Letter to Acquire York Pharma plc
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 17 Mar 2009
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
Biopharmaceuticals

HSMN NewsFeed - 9 Mar 2009
ULURU Inc. Announces Senior Management Change
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Feb 2009
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Feb 2009
Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 13 Jan 2009
Cephalon Signs Option Agreement to Acquire Ception Therapeutics
Biopharmaceuticals

HSMN NewsFeed - 9 Dec 2008
AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain
Biopharmaceuticals Pain Management

HSMN NewsFeed - 26 Nov 2008
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 3 Nov 2008
Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 21 Oct 2008
Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 3 Jun 2008
Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
Biopharmaceuticals Litigation Generics

HSMN NewsFeed - 3 Jun 2008
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 6 May 2008
Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Apr 2008
Cephalon Notified of Generic Fentanyl Buccal Tablet Filing
Biopharmaceuticals Generics

HSMN NewsFeed - 14 Apr 2008
Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 31 Mar 2008
Acusphere Licenses Hydrophobic Drug Delivery System to Cephalon for $10 Million
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 20 Mar 2008
Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 6 Mar 2008
inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
Biopharmaceuticals

HSMN NewsFeed - 20 Feb 2008
ULURU Inc. Provides Details On Altrazeal(TM) Launch
Devices Wound Care

HSMN NewsFeed - 19 Feb 2008
FDA Accepts TREANDA(R) New Drug Application for the Treatment of Relapsed Indolent Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Jan 2008
Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Biopharmaceuticals

HSMN NewsFeed - 24 Jan 2008
Cephalon's EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 31 Dec 2007
Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 17 Dec 2007
Auxilium Pharmaceuticals, Inc. Completes Enrollment in Two Phase III Clinical Trials of XIAFLEX(TM) for Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 1 Nov 2007
Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2007
Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Sep 2007
ULURU Inc. Announces the Appointment of Renaat Van den Hooff to Join Executive Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Sep 2007
Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Sep 2007
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 10 Sep 2007
Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX(TM) U.S. Pivotal Phase III Study
Biopharmaceuticals

HSMN NewsFeed - 5 Sep 2007
BDSI Secures U.S. Commercial Partnership for BEMA(TM) Fentanyl with Meda AB
Biopharmaceuticals Oncology Pain Management

HSMN NewsFeed - 29 Aug 2007
FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 23 Aug 2007
Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 16 Aug 2007
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 16 Aug 2007
Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Jul 2007
The Journal of Hand Surgery Publishes Initial Phase III Data on XIAFLEX(TM) (formerly known as AA4500), Auxilium's Investigational Treatment for Patients with Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 28 Jun 2007
Cephalon Announces Plans for New NDA Filing for TREANDA(R)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Jun 2007
Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of Excessive Sleepiness Associated with Three Disorders
Biopharmaceuticals FDA

HSMN NewsFeed - 22 May 2007
Auxilium Announces New Data That Show Total Testosterone Blood Levels Increase Significantly Following Switch from AndroGel(R) to Testim(R)
Biopharmaceuticals

HSMN NewsFeed - 14 May 2007
BDSI Announces Positive Key Secondary Efficacy Endpoint Results for BEMA(TM) Fentanyl
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 1 May 2007
Cephalon Presents Positive Results for FENTORA(R) in Breakthrough Pain Associated with Neuropathic Conditions
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 25 Apr 2007
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 19 Apr 2007
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 30 Mar 2007
Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Mar 2007
Cephalon Files Marketing Application for Approval of a Fentanyl Effervescent Buccal Tablet in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Feb 2007
Auxilium Announces Results from Phase III Trial that Show AA4500 Successful in Treating Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 24 Jan 2007
Cephalon Comments on Study of its Leukemia Treatment Led by National Cancer Institute Cooperative Group
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 8 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 2 Jan 2007
Antares ATD(TM) Formulation Enters Phase III Study
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 18 Dec 2006
Antares Receives First FDA Approval of ATD(TM) Gel Platform
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Dec 2006
European Zindaclin Licensing Agreements Restructured; Zindaclin Rights for U.S. Market Licensed; Revenue From Zindaclin Projected at $2.5 Million in 2007
Biopharmaceuticals Licensing

HSMN NewsFeed - 12 Dec 2006
Auxilium Pharmaceuticals, Inc. Announces Distribution Agreement With Paladin Labs for Testim(R) in Canada
Biopharmaceuticals Distribution

HSMN NewsFeed - 7 Dec 2006
Cephalon Provides Update Related to Final NUVIGIL(TM) Labeling
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Dec 2006
Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of CIMA LABS
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Nov 2006
Auxilium Pharmaceuticals, Inc. Initiates Phase III Trials for AA4500 in Dupuytren's Contracture
Biopharmaceuticals

HSMN NewsFeed - 18 Oct 2006
Auxilium Pharmaceuticals Announces R&D Portfolio Change
Biopharmaceuticals

HSMN NewsFeed - 11 Oct 2006
Cephalon Announces Positive Results for FENTORA(TM) (fentanyl buccal tablet) for Breakthrough Pain in Patients with Chronic Low Back Pain
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 4 Oct 2006
Antares Pharma to Supply Teva with Innovative Needle-Free Injection System
Biopharmaceuticals

HSMN NewsFeed - 27 Sep 2006
Barr Launches Generic ACTIQ(R) Cancer Pain Management Product
Biopharmaceuticals Generics Drug Delivery

HSMN NewsFeed - 25 Sep 2006
Cephalon Receives FDA Approval of FENTORA(TM) (fentanyl buccal tablet) for the Management of Breakthrough Pain in Patients with Cancer
Biopharmaceuticals Oncology Drug Delivery FDA

HSMN NewsFeed - 18 Jul 2006
Antares Pharma Announces Licensing Agreement with Teva for Novel Injector Device
Biopharmaceuticals Devices Drug Delivery Licensing

HSMN NewsFeed - 29 Jun 2006
Cephalon Receives Approvable Letter for FENTORA(TM) (fentanyl buccal tablet) for Management of Breakthrough Pain in Patients with Cancer
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 29 Jun 2006
Auxilium Pharmaceuticals Announces Start of U.S. Phase III Pivotal Trial of Testosterone Transmucosal Film (AA2600) for Hypogonadism
Biopharmaceuticals

HSMN NewsFeed - 26 Jun 2006
Cephalon Announces Results from GABITRIL(R) Clinical Program in Generalized Anxiety Disorder
Biopharmaceuticals

HSMN NewsFeed - 26 Jun 2006
Auxilium Appoints Armando Anido as Chief Executive Officer and President
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jun 2006
Antares Reports On End of Phase II Meeting with FDA for Anturol(TM)
Biopharmaceuticals Urology

HSMN NewsFeed - 23 May 2006
Auxilium Pharmaceuticals Receives Approval to Sell Testim(R) in Canada
Biopharmaceuticals Regulatory

Return to NewsFeed

Additional items found! 99

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 99 additional stories matching:
transmucosal
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!